The data for this analysis indicated that the prognosis of breast cancer patients with ALDH1A1+ was poorer than that of the ALDH1A1- patients regardless of the indicators used (OS/SS/RS or DFS/MFS/RFS). Here, ALDH1A1 is linked to breast cancer.